Association between plasma oxidized low-density lipoprotein and diabetic nephropathy (Q44126485)

30 November 2017

Association between plasma oxidized low-density lipoprotein and diabetic nephropathy (English)

1 reference

30 November 2017

1 reference

Noriko Ujihara

1

1 reference

30 November 2017

Yumiko Sakka

2

1 reference

30 November 2017

Masanobu Takeda

3

1 reference

30 November 2017

Michiyo Hirayama

4

1 reference

30 November 2017

Akiko Ishii

5

1 reference

30 November 2017

Osamu Tomonaga

6

1 reference

30 November 2017

Tetsuya Babazono

7

1 reference

30 November 2017

Chieko Takahashi

8

1 reference

30 November 2017

Katsuko Yamashita

9

1 reference

30 November 2017

Yasuhiko Iwamoto

10

1 reference

30 November 2017

1 November 2002

1 reference

Diabetes Research and Clinical Practice

30 November 2017

1 reference

30 November 2017

58

1 reference

30 November 2017

2

1 reference

30 November 2017

109-114

1 reference

Glycosylated low density lipoprotein is more sensitive to oxidation: implications for the diabetic patient?

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900134-1

7 January 2021

Oxidized Low Density Lipoproteins: a Role in the Pathogenesis of Atherosclerosis in Diabetes?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900134-1

7 January 2021

Relation between serum cholesterol and diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900134-1

7 January 2021

Lipid peroxide level in plasma of diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900134-1

7 January 2021

Cholesterol-lowering therapy may retard the progression of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900134-1

7 January 2021

Cholesterol: a renal risk factor in diabetic nephropathy?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900134-1

7 January 2021

Uptake and metabolism of lipoproteins from patients with diabetes mellitus type II by glomerular epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900134-1

7 January 2021

LDL stimulates mesangial fibronectin production and chemoattractant expression

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900134-1

7 January 2021

Low-density lipoprotein stimulates the expression of macrophage colony-stimulating factor in glomerular mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900134-1

7 January 2021

Do oxidized lipoproteins contribute to glomerulosclerosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900134-1

7 January 2021

Preferential binding of oxidized LDL to rat glomeruli in vivo and cultured mesangial cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900134-1

7 January 2021

Cellular mechanisms of lipid injury in the glomerulus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900134-1

7 January 2021

Simple and practical sandwich-type enzyme immunoassay for human oxidatively modified low density lipoprotein using antioxidized phosphatidylcholine monoclonal antibody and antihuman apolipoprotein-B antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900134-1

7 January 2021

Anti-cardiolipin antibodies and circulating immune complexes in type 1 diabetes mellitus: increased prevalence and relation to vascular complications.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900134-1

7 January 2021

Serum antioxidant status and oxidized LDL in well-controlled young type 1 diabetic patients with and without subclinical complications

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900134-1

7 January 2021

Autoantibodies to oxidised low density lipoproteins in IDDM are inversely related to metabolic control and microvascular complications

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900134-1

7 January 2021

Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900134-1

7 January 2021

Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900134-1

7 January 2021

Immune response to glycated and oxidized LDL in IDDM patients with and without renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900134-1

7 January 2021

Renal vasoconstriction caused by short-term cholesterol feeding is corrected by thromboxane antagonist or probucol

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900134-1

7 January 2021

Probucol reduces renal injury in the ExHC rat

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900134-1

7 January 2021

High glucose can induce lipid peroxidation in the isolated rat glomeruli

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900134-1

7 January 2021

Electronegative low density lipoprotein subform (LDL-) is increased in type 2 (non-insulin-dependent) microalbuminuric diabetic patients and is closely associated with LDL susceptibility to oxidation.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900134-1

7 January 2021

Thiobarbituric acid reactive substances are increased in the subcutaneous fat tissue of patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900134-1

7 January 2021

The role of lipids in nephrosclerosis and glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900134-1

7 January 2021

Thiobarbituric Acid Reactive Material in Uremic Blood

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900134-1

7 January 2021

Apolipoproteins (A-I, A-II, B), Lp(a) lipoprotein and lecithin: Cholesterol acyltransferase activity in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900134-1

7 January 2021

10.1016/S0168-8227(02)00134-1

Identifiers

DOI

1 reference

30 November 2017

1 reference